Steris (STE) Cost of Revenue (2018 - 2026)

Steris has reported Cost of Revenue for 9 years, with the latest figure at $808.6 million in Q2 2026.

• On a quarterly basis, Cost of Revenue rose 5.96% year-over-year to $808.6 million in Q2 2026; TTM through Jun 2026 was $3.4 billion, a 7.78% increase from a year earlier, with the FY2026 full-year figure at $3.3 billion, up 8.26% from the prior year.
• Cost of Revenue was $808.6 million for Q2 2026 at Steris, down from $891.2 million in the prior quarter.
• The five-year high for Cost of Revenue was $891.2 million in Q1 2026, with the low at $577.8 million in Q2 2022.
• Average Cost of Revenue over 5 years is $738.3 million, with a median of $743.9 million recorded in 2023.
• The largest YoY upside for Cost of Revenue was 29.44% in 2022 against a maximum downside of 15.07% in 2022.
• Over 5 years, Cost of Revenue stood at $634.2 million in 2022, then advanced by 16.31% to $737.7 million in 2023, then gained by 3.05% to $760.2 million in 2024, then rose by 10.59% to $840.7 million in 2025, then slipped by 3.82% to $808.6 million in 2026.
• The last three Cost of Revenue figures came in at $808.6 million (Q2 2026), $891.2 million (Q1 2026), and $840.7 million (Q4 2025), per Business Quant data.